Lonza to help manufacture Human Genome Sciences’ Benlysta
ROCKVILLE, Md. A developer of a new drug for treating lupus has entered a supply agreement with a third-party company based in Switzerland in anticipation of the drug’s approval and eventual growth.
Human Genome Sciences and Lonza announced Tuesday that Lonza would assist HGS in manufacturing the drug Benlysta (belimumab), a treatment for systemic lupus erythematosus, to keep up with future demand. HGS has been developing Benlysta under a partnership with GlaxoSmithKline since 2006.
“Our HGS large-scale manufacturing facility has ample capacity to provide worldwide supply of Benlysta following approval, and for the first two or three years following launch; however, we believe that we will eventually require additional capacity,” HGS VP manufacturing operations Randy Maddux said.
OMI Industries’ Fresh Wave product receives award
BARRINGTON, Ill. OMI Industries on Friday said its eco-friendly, odor-eliminating product line Fresh Wave has received recognition from iParenting Media.
OMI’ Fresh Wave continuous release crystal gel was awarded the 2010 Excellent Products award in the housewares category. Fresh Wave continuous release crystal gel — made of purified water and plant extracts — is designed to eliminate household odors without the use of chemicals.
The iParenting Media awards program is the only consumer awards program certified by ISO 9001:2000, the internationally recognized standard of quality assurance. Reviewers for the awards are a diverse set of parents, experts, licensed childcare centers and schools nationwide.
“We are thrilled to be named an iParenting Media Award winner. We recognize that receiving this award is one of the highest achievements in the consumer goods industry,” said Philip Coffey, president and managing director at OMI Industries. “Our company is committed to developing odor-eliminating solutions that keep homes and businesses smelling clean without the use of harmful chemicals. This is a significant honor for the Fresh Wave crystal gel and an excellent recognition of the design and manufacturing of our products.”
Weis Markets board approves quarterly dividend
SUNBURY, Pa. Weis Markets’ board of directors approved a quarterly dividend of 29 cents per share as of July 19, payable on Aug. 2.
The food retailer operates 164 stores in Pennsylvania, Maryland, New Jersey, New York and West Virginia.